Product
cadonilimab+chemotherapy
1 clinical trial
2 indications
Indication
Esophageal Squamous Cell CarcinomaIndication
Neoadjuvant TherapyClinical trial
A Single-arm, Multicenter, Exploratory Study of Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell CarcinomaStatus: Not yet recruiting, Estimated PCD: 2024-06-01